Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Journal of Medicinal Chemistry
|
April 30, 2004
Conformational analysis of drug-like molecules bound to proteins: an extensive study of ligand reorganization upon binding
Emanuele Perola, Paul S Charifson
Molecular Diversity
|
January 29, 2003
Filtering databases and chemical libraries
Paul S Charifson, W Patrick Walters
Journal of Medicinal Chemistry
|
September 3, 2014
Acidic and basic drugs in medicinal chemistry: a perspective
Paul S Charifson, W Patrick Walters
Journal of Computer-Aided Molecular Design
|
December 20, 2002
Filtering databases and chemical libraries
Paul S Charifson, W Patrick Walters
Proteins
|
June 24, 2004
A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance
Emanuele Perola, W Patrick Walters, Paul S Charifson
Antimicrobial Agents and Chemotherapy
|
April 24, 2004
Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase
Steven Bellon, Jonathan D Parsons, Yunyi Wei, et al.
Antimicrobial Agents and Chemotherapy
|
March 30, 2006
In vitro characterization of the antibacterial spectrum of novel bacterial type II topoisomerase inhibitors of the aminobenzimidazole class
Nagraj Mani, Christian H Gross, Jonathan D Parsons, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 8, 2012
Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part 2: 4-amino-pyrido[2,3-d]pyrimidin-5(8H)-ones
Tiansheng Wang, Leonard Duncan, Wenxin Gu, et al.
Antimicrobial Agents and Chemotherapy
|
November 23, 2006
Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds
Trudy H Grossman, Douglas J Bartels, Steve Mullin, et al.
The Journal of Biological Chemistry
|
March 9, 2026
Structure-Based Discovery of Selective Vaccinia-Related Kinase 1 Inhibitors and Fluorogenic Active-Site Probes
Emma K Crowley-Dolen, Rafael Junqueira Borges, Paul S Charifson, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Journal of Medicinal Chemistry
|
April 30, 2004
Conformational analysis of drug-like molecules bound to proteins: an extensive study of ligand reorganization upon binding
Emanuele Perola, Paul S Charifson
Molecular Diversity
|
January 29, 2003
Filtering databases and chemical libraries
Paul S Charifson, W Patrick Walters
Journal of Medicinal Chemistry
|
September 3, 2014
Acidic and basic drugs in medicinal chemistry: a perspective
Paul S Charifson, W Patrick Walters
Journal of Computer-Aided Molecular Design
|
December 20, 2002
Filtering databases and chemical libraries
Paul S Charifson, W Patrick Walters
Proteins
|
June 24, 2004
A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance
Emanuele Perola, W Patrick Walters, Paul S Charifson
Antimicrobial Agents and Chemotherapy
|
April 24, 2004
Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase
Steven Bellon, Jonathan D Parsons, Yunyi Wei, et al.
Antimicrobial Agents and Chemotherapy
|
March 30, 2006
In vitro characterization of the antibacterial spectrum of novel bacterial type II topoisomerase inhibitors of the aminobenzimidazole class
Nagraj Mani, Christian H Gross, Jonathan D Parsons, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 8, 2012
Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part 2: 4-amino-pyrido[2,3-d]pyrimidin-5(8H)-ones
Tiansheng Wang, Leonard Duncan, Wenxin Gu, et al.
Antimicrobial Agents and Chemotherapy
|
November 23, 2006
Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds
Trudy H Grossman, Douglas J Bartels, Steve Mullin, et al.
The Journal of Biological Chemistry
|
March 9, 2026
Structure-Based Discovery of Selective Vaccinia-Related Kinase 1 Inhibitors and Fluorogenic Active-Site Probes
Emma K Crowley-Dolen, Rafael Junqueira Borges, Paul S Charifson, et al.
Page
of 3